chr11-119025215-C-T
Position:
Variant summary
Our verdict is Pathogenic. Variant got 12 ACMG points: 12P and 0B. PM2PP3_ModeratePP5_Very_Strong
The NM_001164278.2(SLC37A4):c.1165G>A(p.Ala389Thr) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000607 in 1,613,372 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★).
Frequency
Genomes: 𝑓 0.000020 ( 0 hom., cov: 33)
Exomes 𝑓: 0.000065 ( 0 hom. )
Consequence
SLC37A4
NM_001164278.2 missense
NM_001164278.2 missense
Scores
8
2
2
Clinical Significance
Conservation
PhyloP100: 7.37
Genes affected
SLC37A4 (HGNC:4061): (solute carrier family 37 member 4) This gene regulates glucose-6-phosphate transport from the cytoplasm to the lumen of the endoplasmic reticulum, in order to maintain glucose homeostasis. It also plays a role in ATP-mediated calcium sequestration in the lumen of the endoplasmic reticulum. Mutations in this gene have been associated with various forms of glycogen storage disease. Alternative splicing in this gene results in multiple transcript variants.[provided by RefSeq, Aug 2009]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Pathogenic. Variant got 12 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
PP3
MetaRNN computational evidence supports a deleterious effect, 0.848
PP5
Variant 11-119025215-C-T is Pathogenic according to our data. Variant chr11-119025215-C-T is described in ClinVar as [Likely_pathogenic]. Clinvar id is 21298.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr11-119025215-C-T is described in Lovd as [Pathogenic].
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SLC37A4 | NM_001164278.2 | c.1165G>A | p.Ala389Thr | missense_variant | 11/12 | NP_001157750.1 | ||
SLC37A4 | NM_001164277.2 | c.1099G>A | p.Ala367Thr | missense_variant | 10/11 | NP_001157749.1 | ||
SLC37A4 | NM_001164280.2 | c.1099G>A | p.Ala367Thr | missense_variant | 8/9 | NP_001157752.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000197 AC: 3AN: 152206Hom.: 0 Cov.: 33
GnomAD3 genomes
AF:
AC:
3
AN:
152206
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000564 AC: 14AN: 248140Hom.: 0 AF XY: 0.0000668 AC XY: 9AN XY: 134652
GnomAD3 exomes
AF:
AC:
14
AN:
248140
Hom.:
AF XY:
AC XY:
9
AN XY:
134652
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000650 AC: 95AN: 1461166Hom.: 0 Cov.: 34 AF XY: 0.0000743 AC XY: 54AN XY: 726840
GnomAD4 exome
AF:
AC:
95
AN:
1461166
Hom.:
Cov.:
34
AF XY:
AC XY:
54
AN XY:
726840
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000197 AC: 3AN: 152206Hom.: 0 Cov.: 33 AF XY: 0.0000269 AC XY: 2AN XY: 74350
GnomAD4 genome
AF:
AC:
3
AN:
152206
Hom.:
Cov.:
33
AF XY:
AC XY:
2
AN XY:
74350
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
TwinsUK
AF:
AC:
0
ALSPAC
AF:
AC:
2
ExAC
AF:
AC:
6
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Pathogenic/Likely pathogenic
Submissions summary: Pathogenic:4Uncertain:1Other:1
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Glucose-6-phosphate transport defect Pathogenic:4
Likely pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Oct 27, 2023 | This sequence change replaces alanine, which is neutral and non-polar, with threonine, which is neutral and polar, at codon 367 of the SLC37A4 protein (p.Ala367Thr). This variant is present in population databases (rs80356492, gnomAD 0.02%). This missense change has been observed in individuals with autosomal recessive glycogen storage disease (PMID: 10518030, 10923042, 32300528). This variant is also known as c.1268G>A. ClinVar contains an entry for this variant (Variation ID: 21298). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt SLC37A4 protein function with a positive predictive value of 80%. Experimental studies have shown that this missense change affects SLC37A4 function (PMID: 12444104, 18835800). In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. - |
Pathogenic, criteria provided, single submitter | clinical testing | Baylor Genetics | Mar 19, 2024 | - - |
Likely pathogenic, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Jan 06, 2023 | Variant summary: SLC37A4 c.1099G>A (p.Ala367Thr) results in a non-conservative amino acid change located in the Major facilitator superfamily domain (IPR020846) of the encoded protein sequence. Three of three in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 5.6e-05 in 248140 control chromosomes. This frequency is not significantly higher than estimated for a pathogenic variant in SLC37A4 causing Glycogen Storage Disease Type Ib (5.6e-05 vs 0.0012), allowing no conclusion about variant significance. c.1099G>A has been reported in the literature as a compound heterozygous genotype in individuals affected with Glycogen Storage Disease Type Ib (example, Galli_1999, Santer_2000, Trioche_2004, Melis_2005, Wicker_2020). These data indicate that the variant is likely to be associated with disease. At least one publication reports experimental evidence evaluating an impact on protein function. The most pronounced variant effect results in 23% of normal Microsomal G6P uptake activity in vitro (example, Chen_2002). Three clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014 without evidence for independent evaluation (VUS, n=2; Likely pathogenic, n=1). Based on the evidence outlined above, the variant was classified as likely pathogenic. - |
Likely pathogenic, criteria provided, single submitter | clinical testing | Myriad Genetics, Inc. | Nov 01, 2021 | NM_001164277.1(SLC37A4):c.1099G>A(A367T) is a missense variant classified as likely pathogenic in the context of glycogen storage disease type Ib. A367T has been observed in cases with relevant disease (PMID: 15669677, 15906092, 10923042, 32300528, Savostyanov_2017_(no PMID; article), Odlotilova_2013_(no PMID; thesis)). Functional assessments of this variant are available in the literature (PMID: 12444104, 18835800, 21983240). A367T has been observed in population frequency databases (gnomAD: SAS 0.02%). In summary, NM_001164277.1(SLC37A4):c.1099G>A(A367T) is a missense variant that has been observed more frequently in cases with the relevant disease than in healthy populations. Please note: this variant was assessed in the context of healthy population screening. - |
not provided Uncertain:1Other:1
not provided, no classification provided | literature only | UniProtKB/Swiss-Prot | - | - - |
Uncertain significance, flagged submission | clinical testing | Eurofins Ntd Llc (ga) | Feb 03, 2017 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
BayesDel_addAF
Pathogenic
D
BayesDel_noAF
Pathogenic
CADD
Pathogenic
DANN
Benign
DEOGEN2
Uncertain
T;T;T;T
FATHMM_MKL
Pathogenic
D
LIST_S2
Pathogenic
.;D;D;D
M_CAP
Uncertain
D
MetaRNN
Pathogenic
D;D;D;D
PrimateAI
Pathogenic
D
Sift4G
Pathogenic
D;D;D;D
Vest4
MVP
MPC
0.17
GERP RS
RBP_binding_hub_radar
RBP_regulation_power_radar
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at